Skip to main content

Table 1 Demographical and clinical data for the study population a

From: Anti-Saccharomyces cerevisiae antibodies (ASCA) are associated with body fat mass and systemic inflammation, but not with dietary yeast consumption: a cross-sectional study

  All patients, n = 140 b
Age, years 43.1 (8.7)
Gender (male/female) 31 (22%)/109 (78%)
Ethnic Nordic background 138 (99%)
Height, cm 169 (149–197)
Weight, kg 120 (90–192)
BMI, kg/m2 41.6 (35–55)
Body fat, percentage of body weight 46.8 (31–51)
Body fat mass, kg 54.1 (39–81)
Smoking (never/former/current) 55 (39%)/60 (43%)/25 (18%)
Previous or present co-morbidity
 Diabetes mellitus 26 (19%)
 Polycystic ovary syndrome 7 (6.4%)
 Hypertension 46 (33%)
 Angina pectoris 1 (0.7%)
 Myocardial infarction 2 (1.4%)
 Stroke 3 (2.1%)
 Fibromyalgia 25 (18%)
 Hypothyroidism 18 (13%)
 Hyperthyroidism 1 (0.7%)
 Gallstones 21 (15%)
 Irritable bowel syndrome (Rome III) 35 (26%)
 Chronic obstructive pulmonary disease 3 (2.1%)
 Asthma 34 (24%)
 Hay fever 19 (14%)
 Osteoporosis 0 (0%)
 Asked for help for psychological problems 28 (20%)
 Mental distress (HSCL-10 score > 1.85) 34 (24%)
  1. aData are expressed as mean (SD), median (min-max) and n (%)
  2. bAll data are based on n = 140 with the following exceptions: 1) Irritable bowel syndrome: n = 135. 2) Polycystic ovary syndrome; n = 109 (females only)